Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline at the abutment-implant interface for prevention of crestal bone resorption
IRCT20180222038827N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of doxycycline in peri-implant mucositis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Bleeding on probing, Probing depth and 1 more. Started Apr 2011; status: completed.
02
Drugs
doxycycline
03
Conditions
peri-implant mucositis
Beyond the preview
Go deeper on IRCT20180222038827N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180222038827N2.